BSE Live
Oct 17, 16:01Prev. Close
1274.65
Open Price
1286.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 17, 16:01Prev. Close
1275.70
Open Price
1281.00
Bid Price (Qty.)
1243.90 (114)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Thyrocare Technologies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | 151.21 | 98.22 | 81.07 | 207.38 | 161.28 | |
Net CashFlow From Operating Activities | 190.76 | 155.19 | 120.02 | 105.68 | 110.41 | |
Net Cash Used In Investing Activities | -54.70 | -80.29 | -31.65 | -12.32 | -53.19 | |
Net Cash Used From Financing Activities | -124.44 | -83.71 | -87.50 | -86.91 | -57.05 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | 11.62 | -8.81 | 0.87 | 6.45 | 0.17 | |
Cash And Cash Equivalents Begin of Year | 3.56 | 12.37 | 11.50 | 5.05 | 4.88 | |
Cash And Cash Equivalents End Of Year | 15.18 | 3.56 | 12.37 | 11.50 | 5.05 |
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
24.04.2025
Thyrocare Techn Consolidated March 2025 Net Sales at Rs 187.16 crore, up 21.34% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss